GSE264723 GSE264730 IDH1 inhibition 1 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE264723_GSE264730_IDH1 inhibition_1_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE264723_GSE264730_IDH1 inhibition_1_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE264723_GSE264730_IDH1 inhibition_1_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE264723_GSE264730_IDH1 inhibition_1_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 1

Gene

H2A clustered histone 11

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 662

Gene

MIR1915 host gene

Gene

HERC2 pseudogene 2

Gene

H2A clustered histone 4

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

long intergenic non-protein coding RNA 641

  • Gene

    small nucleolar RNA host gene 1


  • Gene

    H2A clustered histone 11


  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 662



  • Gene

    HERC2 pseudogene 2


  • Gene

    H2A clustered histone 4


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    long intergenic non-protein coding RNA 641

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.